New Cousteau-Linked...
Health Care: Drugs
ARCA biopharma Inc. (ABIO: NASDAQ)
$0.48 -0.02 | -3.81%
06/04/12 - 01:42 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 5.94M | 7.02M | 7.76M | 35.89M |
| Receivables | 0.00 | 0.00 | 0.00 | 441.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 269.00K | 137.00K | 522.00K | 715.00K |
| Total Current Assets | 6.21M | 7.16M | 8.28M | 52.13M |
| Property, Plant & Equipment, Gross | 533.00K | 1.67M | 1.67M | 18.63M |
| Accumulated Depreciation & Depletion | 467.00K | 976.00K | 641.00K | 11.80M |
| Property, Plant & Equipment, Net | 66.00K | 690.00K | 1.03M | 6.83M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 224.00K | 304.00K | 61.00K | 7.08M |
| Total Non-Current Assets | 290.00K | 994.00K | 1.09M | 13.92M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 6.50M | 8.16M | 9.37M | 66.04M |
| Accounts Payable | 260.00K | 388.00K | 533.00K | 1.26M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 368.00K |
| Total Current Liabilities | 754.00K | 1.19M | 1.64M | 11.35M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 16.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 195.00K | 316.00K | 12.19M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 16.00K | 195.00K | 316.00K | 12.19M |
| Total Liabilities | 770.00K | 1.38M | 1.96M | 23.54M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 5.73M | 6.77M | 7.41M | 42.51M |
| Common Par | 12.00K | 9.00K | 8.00K | 3.00K |
| Additional Paid In Capital | 69.39M | 65.07M | 57.29M | 542.93M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -63.67M | -58.31M | -49.89M | -500.44M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 11.00K |
| Total Capitalization | 5.73M | 6.77M | 7.41M | 42.51M |
| Total Equity | 5.73M | 6.77M | 7.41M | 42.51M |
| Total Liabilities & Stock Equity | 6.50M | 8.16M | 9.37M | 66.04M |
| Total Common Shares Outstanding | 12.18M | 8.83M | 7.62M | 7.62M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 10.04M | 8.51M | 7.09M | 2.68M |
| Diluted Weighted Shares Outstanding | 10.04M | 8.51M | 7.09M | 2.68M |
| Number of Employees | 11 | 21 | 22 | 81 |
| Number of Part-Time Employees | 3 | 1 | 0 | 4 |
Portfolios with ABIO
- Portfolio NameUser Type
- Userbuddy62370 Portfolio 1
- UserKumaran
- UserSUPRATRADE NEW-BUY LIST-240...
Latest ABIO Headlines from TheStreet
- InfoLogix, Netlist: Midday Volume Plays 05.17.10 | 01:05 pm
- Arca BioPharma Patent Deja Vu: BioBuzz 03.29.10 | 06:03 am
- Sirius XM, ARCA biopharma: Early Volume Plays 03.26.10 | 09:03 am
- Brazilian Telecom, Agria: Midday Volume Plays 11.24.09 | 01:11 pm
- ARCA, FortuNet: Midday Volume Plays 11.23.09 | 01:11 pm
- Funds Sell $4M Worth of Pain Therapeutics 06.11.09 | 09:06 am
- Ford, Deere, Cisco Systems Are Big Movers 06.01.09 | 05:06 pm
- FDA Wants ARCA To Run More Tests On Heart Drug 06.01.09 | 11:06 am
- The Second Dendreon Wave
05.18.09 | 02:05 pm
Press Releases for ABIO
- GencaroTM's Norepinephrine Lowering Likely Contributes To Its Effect In Atrial Fibrillation Prevention - Business Wire 03.26.12 | 12:03 pm
- GencaroTM Atrial Fibrillation Data Selected For Presentation At American College Of Cardiology 61st Annual Scientific Session & Expo - Business Wire 03.20.12 | 08:03 am
- ARCA Biopharma Announces Additional Patent Issued For Methods For Treatment With Bucindolol Based On Genotype Of Patient - Business Wire 01.19.12 | 08:01 am
- CEO Of ARCA Biopharma To Speak On Use Of Biomarkers And Implications Of Personalized Medicine At New Paradigms Conference On January 12, 2012 - Business Wire 01.05.12 | 08:01 am
- Dr. Michael Bristow, CEO, ARCA Biopharma (Photo: Business Wire) - Business Wire 12.30.11 | 08:12 am
- ARCA Biopharma Announces Private Placement Of $1.75 Million With Institutional Investors - Business Wire 12.22.11 | 08:12 am
- Kaplan Meier Curves By Beta-1 389 Arg/Gly Polymorphism. (Graphic: Business Wire) - Business Wire 11.16.11 | 11:11 am
- Dr. Michael Bristow, CEO, ARCA Biopharma (Photo: Business Wire) - Business Wire 11.11.11 | 08:11 am
- Two GencaroTM Atrial Fibrillation Abstracts Accepted For Presentation At The American Heart Association Scientific Sessions 2011 - Business Wire 08.10.11 | 08:08 am
- ARCA Biopharma Announces Planned Expansion Of Gencaro Development To Atrial Fibrillation - Business Wire 05.26.11 | 08:05 am
Partner Headlines for ABIO
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Top Percentage Gainers and Losers as of 2pm 05/13/11 (ABIO, GFRE, DDS, APL, DF, VRML, DAR, SWSH, ONTY, GS, RMBS, LPHI, GGS, CA, NVDA, IMRS, MNTX, MPG, GTY) - Benzinga 05.13.11 | 02:05 pm
- Morning Market Movers (ABIO, LBIX, CGNX, AEIS) - Benzinga 05.03.11 | 09:05 am
- UPDATE 1-Arca reaches agreement with FDA on heart-drug study - Reuters 05.17.10 | 09:05 am
- UPDATE 1-ARCA gets U.S. patent related to heart drug; shrs soar - Reuters 03.26.10 | 10:03 am
